Toxicities and Response Rates of Secondary CNS Lymphoma After Adoptive Immunotherapy With CD19-Directed Chimeric Antigen Receptor T Cells
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Toxicities and Response Rates of Secondary CNS Lymphoma After Adoptive Immunotherapy With CD19-Directed Chimeric Antigen Receptor T Cells
Neurology 2022 May 24;98(21)884-889, P Karschnia, K Rejeski, M Winkelmann, F Schöberl, VL Bücklein, V Blumenberg, C Schmidt, J Blobner, M von Bergwelt-Baildon, JC Tonn, WG Kunz, M Subklewe, L von BaumgartenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.